EmeraMed Newsletter – February 2019
February 2019 Newsletter for EmeraMed Ltd, a biotechnology firm developing the lipophilic, blood-brain-barrier passing metal chelator & antioxidant Irminix®
February 2019 Newsletter for EmeraMed Ltd, a biotechnology firm developing the lipophilic, blood-brain-barrier passing metal chelator & antioxidant Irminix®
Join our mailing list to receive the latest news and updates from our team.
Thanks for your interest in EmeraMed!